The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids
Open Access
Abstract
Connective tissue growth factor (CTGF) is involved in the regulation of extracellular matrix (ECM) production. Elevated levels of CTGF can be found in plasma from patients with liver fibrosis and in experimental animal models of liver fibrosis, but the exact role of CTGF in, e.g., diet-induced human liver fibrosis is not entirely known. To address this question, we utilized a 3D human liver co-culture spheroid model composed of hepatocytes and non-parenchymal cells, in which fibrosis is induced by TGF-β1, CTGF or free fatty acids (FFA). Treatment of the spheroids with TGF-β1 or FFA increased COL1A1 deposition as well as the expression of TGF-β1 and CTGF. Recombinant CTGF, as well as angiotensin II, caused increased expression and/or production of CTGF, TGF-β1, COL1A1, LOX, and IL-6. In addition, silencing of CTGF reduced both TGF-β1- and FFA-induced COL1A1 deposition. Furthermore, we found that IL-6 induced CTGF, COL1A1 and TGF-β1 production, suggesting that IL-6 is a mediator in the pathway of CTGF-induced fibrosis. Taken together, our data indicate a specific role for CTGF and CTGF downstream signaling pathways for the development of liver inflammation and fibrosis in the human 3D liver spheroid model.Keywords
Funding Information
- ERC Advanced Grant (AdG) project HEPASPHER (742020, 2018-05766)
- Swedish Research Council (742020, 2018-05766)
This publication has 56 references indexed in Scilit:
- Inhibition of connective tissue growth factor suppresses hepatic stellate cell activation in vitro and prevents liver fibrosis in vivoClinical and Experimental Medicine, 2013
- CTGF Increases IL-6 Expression in Human Synovial Fibroblasts through Integrin-Dependent Signaling PathwayPLOS ONE, 2012
- CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosisFibrogenesis & Tissue Repair, 2012
- Connective tissue growth factor reacts as an IL-6/STAT3-regulated hepatic negative acute phase proteinWorld Journal of Gastroenterology, 2011
- Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cellsExperimental Eye Research, 2009
- Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseasesLiver International, 2008
- Glucocorticoids activate TGF-β induced PAI-1 and CTGF expression in rat hepatocytesComparative Hepatology, 2007
- Down‐regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosisWound Repair and Regeneration, 2004
- An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cellsBritish Journal of Pharmacology, 2003
- Expression of connective tissue growth factor in experimental rat and human liver fibrosisHepatology, 1999